Bryan T.R. Rowland - Dec 15, 2023 Form 4 Insider Report for Vertex, Inc. (VERX)

Role
GENERAL COUNSEL
Signature
/s/ Lisa Coleman, Attorney-in-Fact
Stock symbol
VERX
Transactions as of
Dec 15, 2023
Transactions value $
-$1,602,906
Form type
4
Date filed
12/19/2023, 04:19 PM
Previous filing
Mar 10, 2023
Next filing
Feb 15, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VERX Class A Common Stock Options Exercise $198K +62.4K +1429% $3.17* 66.8K Dec 15, 2023 Direct F1
transaction VERX Class A Common Stock Sale -$1.68M -62.4K -93.46% $26.96 4.37K Dec 15, 2023 Direct F2
transaction VERX Class A Common Stock Sale -$117K -4.37K -100% $26.86 0 Dec 15, 2023 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VERX Stock Option Options Exercise $0 -62.4K -100% $0.00* 0 Dec 15, 2023 Class A Common Stock 62.4K $3.17 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 458 shares acquired through the Company's Employee Stock Purchase Plan.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $26.66 to $27.24, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $26.68 to $27.33, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F4 This option became exercisable as to 50% of the shares on the date of grant and with respect to the remaining shares on February 9, 2023.